Back to top
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Nucor Corporation (NUE) - free report >>
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Nucor Corporation (NUE) - free report >>
Image: Bigstock
Best Momentum Stock to Buy for March 29th
Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, March 29th:
Nucor (NUE - Free Report) : This company which is a leading producer of structural steel, steel bars, steel joists, steel deck and cold finished bars in the United States, has a Zacks Rank #1(Strong Buy), and witnessed the Zacks Consensus Estimate for its current year earnings increasing 10.7% over the last 60 days.
Nucor Corporation Price and Consensus
Nucor Corporation price-consensus-chart | Nucor Corporation Quote
Nucor’s shares gained 11.0% over the last three month compared with the S&P 500’s gain of 3.5%. The company possesses a Momentum Score of A.
Nucor Corporation Price
Nucor Corporation price | Nucor Corporation Quote
Enfusion (ENFN - Free Report) : This company which is a provider of cloud-based investment management software and services, has a Zacks Rank #1, and witnessed the Zacks Consensus Estimate for its current year earnings increasing 5.6% over the last 60 days.
Enfusion, Inc. Price and Consensus
Enfusion, Inc. price-consensus-chart | Enfusion, Inc. Quote
Enfusion’s shares gained 5.5% over the last month compared with the S&P 500’s gain of 3.5%. The company possesses a Momentum Score of A.
Enfusion, Inc. Price
Enfusion, Inc. price | Enfusion, Inc. Quote
Trinity Capital (TRIN - Free Report) : This internally managed business development company that provides debt, including loans and equipment financing, to growth stage companies, including venture-backed companies and companies with institutional equity investors, has a Zacks Rank #1, and witnessed the Zacks Consensus Estimate for its current year earnings increasing 9.0% over the last 60 days.
Trinity Capital Inc. Price and Consensus
Trinity Capital Inc. price-consensus-chart | Trinity Capital Inc. Quote
Trinity Capital’s shares gained 23.9% over the last month compared with the S&P 500’s gain of 3.5%. The company possesses a Momentum Score of A.
Trinity Capital Inc. Price
Trinity Capital Inc. price | Trinity Capital Inc. Quote
See the full list of top ranked stocks here
Learn more about the Momentum score and how it is calculated here.